by ecmamerica | Jun 13, 2019 | Resources
This post was originally published on this siteThe field of biotechs developing treatments for Duchenne muscular dystrophy became more crowded this week, with biotech startup Dyne setting its sights on the muscle-wasting rare disease. Read more. The post Undeterred by...
by ecmamerica | Jun 13, 2019 | Resources
This post was originally published on this siteAkrevia Therapeutics is on a mission to make immunotherapies safer. The startup, based in the LabCentral incubator in Cambridge, Mass., is working on drug candidates that act much like therapies that are already on the...
by ecmamerica | Jun 13, 2019 | Resources
This post was originally published on this siteA team led by researchers at the New York University School of Medicine found artificially changing the length of specific neuronal waves could improve short-term memory in rats, offering a potential new approach for...
by ecmamerica | Jun 13, 2019 | Resources
This post was originally published on this siteGilead Sciences has entered into an infectious disease antibody discovery pact with AbCellera. The deal sees Gilead task AbCellera with using technologies to find rare antibodies with certain...
by ecmamerica | Jun 13, 2019 | Resources
This post was originally published on this siteClinical trial specialist Medidata is being bought out by France’s Dassault Systemes in a deal designed to help the tech firm diversify deeper into the biopharma services...
